NCBiotech News

We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.

The Scullion Strategy Group, based in Greensboro, has inked an exclusive option agreement with Boston-based Brigham and Women’s Hospital (BWH) to license patent rights in semen analysis for veterinary use.

Morrisville-based TransEnterix has received clearance from the U.S. Food and Drug Administration to begin selling its Senhance surgical robotic system.

German conglomerate Bayer AG has agreed to sell crop science businesses for $7 billion to BASF, including its R&D employees and campus in the Research Triangle Park.

An appearance at a North Carolina Biotechnology Center event in 2016 convinced the CEO of a high-tech ag biotech startup to move his company from Massachusetts to the Research Triangle.

New genetic editing tools raise a host of ethical, legal, and regulatory questions in agricultural biotechnology innovation. That is the topic scientists, legal experts, and industry executives will tackle at an unusual event at the North Carolina Biotechnology Center Oct. 24.

The Medical Innovators Collaborative (MEDIC) has launched its first fundraising campaign to support its work as a medical device hub in the Research Triangle Park.

PlantResponse, a plant biotechnology company based in Madrid, has established its North American headquarters in North Carolina’s Research Triangle Park and is looking for permanent facilities in the area.

Pelican Therapeutics, a subsidiary of Durham-based Heat Biologics Inc., has entered a service agreement with Geneva-based Selexis SA to advance development of Pelican’s cancer-fighting therapy candidates.

Fennec Pharmaceuticals, a specialty pharmaceutical company with executive headquarters in the Research Triangle Park, is making a difference for children with hearing loss.

Greensboro-based Piedmont Animal Health, a developer of health products for companion animals, has gained a strategic equity investment from the life science division of Sumitomo Corp., a Fortune 500 company based in Tokyo.

Humacyte, a Morrisville-based regenerative medicine company bootstrapped with early funding from the North Carolina Biotechnology Center, has received more than $18 million from three sources to help test and commercialize its bioengineered blood vessel, Humacyl.

Executives from two ag biotech companies that raised major funding in 2017 shared some of their success secrets to a group of North Carolina peers this week.

Foundation Medicine, a Cambridge, Massachusetts firm selling genomic cancer tests, opened a precision health laboratory in Morrisville last year that it is growing into a major facility.

Bioscience briefs with names making news

Executives from two ag biotech companies that raised north of $20 million in capital recently will offer their insights on “Secrets for Raising Capital to Build Startups” at the AgBiotech Professional Forum September 27 at the North Carolina Biotechnology Center.